drugset
drugset / Trial / NCT05388981

Study of Single Doses of SBT115301 in Healthy Participants

NCT05388981 ↗

Phase 1 Completed 40 enrolled Sonoma Biotherapeutics, Inc.
RandomizedSequentialQuadruple-blindTreatment

Summary

This study will test the safety and effects of SBT115301 when given as a single dose to healthy adult volunteers. It is the first study being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown. Some participants will receive placebo, and neither the participants or the study staff will know what drug (SBT115301 or placebo) is being given.

Timeline

Start
2022-07-25
Primary completion
2024-01-03
Completion
2024-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject SBT115301 Protein / enzyme biologic — Intramuscular

Indications

No indication recorded.